Beylerli, Ozal,
Gareev, Ilgiz,
Musaev, Elmar,
Roumiantsev, Sergey,
Chekhonin, Vladimir,
Ahmad, Aamir,
Chao, Yuan,
Yang, Guang (2025) for innovative precision
therapies. This review examines the current state of
targeted therapies for intracranial
processes of VTCs for effective
therapy and diagnosis. Significant progress has been made in VTC research
, such as therapeutic
targets and non-invasive diagnostic/prognostic biomarker tools. © 2024, The Author(s).
Gareev, Ilgiz,
Beylerli, Ozal,
Tamrazov, Rasim,
Ilyasova, Tatiana,
Shumadalova, Alina,
Du, Weijie,
Yang, Baofeng (2023) effectively
target various structures within the central nervous system (CNS). MiRNA-based
therapy stands out
of global death. The purpose of our bioinformatics analysis was to detect viable pathophysiological
targetsBEYLERLI, OZAL,
BEERAKA, NARASIMHA M.,
GAREEV, ILGIZ,
PAVLOV, VALENTIN,
YANG, GUANG,
LIANG, YANCHAO,
ALIEV, GJUMRAKCH (2020) single-stranded RNA molecules that can influence post-transcriptional regulation by controlling
target for comprehensive clinical trials to establish the efficacy of polyphenol-based
therapies targeting nc
their possible applications in gene
therapy and as
targets for novel treatment modalities. © 2023 The Authors
Beylerli, Ozal,
Ju, Jiaming,
Beilerli, Aferin,
Gareev, Ilgiz,
Shumadalova, Alina,
Ilyasova, Tatiana,
Bai, Yunlong,
Yang, Baofeng (2023) drug
therapy for AF patients is often ineffective and may have adverse effects. Radiofrequency ablation
Xun, Xu,,
Liang, Yuan,
Gareev, Ilgiz,
Liang, Yanchao,
Liu, Rui,
Wang, Ning,
Yang, Guang (2023) and chemoradiotherapy resistance, we discussed the feasibility for lncRNAs as therapeutic
targets. Finally